A double-blind, randomized study to evaluate plasma prolactin levels in healthy volunteers after single oral doses of lorazepam

A double-blind, randomized study to evaluate plasma prolactin levels in healthy volunteers after single oral doses of lorazepam - Prolactin levels after single oral doses of lorazepam

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37691

Enrollment

Registered

2012-06-11

Start date

2012-06-12

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperprolactinemia increased prolactin levels

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Not applicable. This study will consist of performing additional analysis of prolactin concentration in blood samples obtained from healthy volunteers in two other (separate) studies. Signed informed consent forms from all volunteers are available and cover this additional analysis. As a result, no new volunteers will be included

Exclusion criteria

Exclusion criteria: Not applicable. This study will consist of performing additional analysis of prolactin concentration in blood samples obtained from healthy volunteers in two other (separate) studies. Signed informed consent forms from all volunteers are available and cover this additional analysis. As a result, no new volunteers will be included

Design outcomes

Primary

Measure	Time frame
Plasma prolactin concentration	—

Countries

Netherlands

Outcome results